A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes

NCT04109547 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

521

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Oral semaglutide
DRUG: Placebo

Sponsor

Novo Nordisk A/S